A notable advancement in diabetes treatment is emerging with the approval of tirzepatide in a 45mg form. This innovative formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://modernbookmarks.com/story21094566/groundbreaking-development-tirzepatide-45mg-for-glucose-control